Status:
COMPLETED
Mouse Allergen and Asthma Intervention Trial
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Boston Children's Hospital
Columbia University
Conditions:
Asthma
Mouse Allergy
Eligibility:
All Genders
6-17 years
Phase:
PHASE3
Brief Summary
The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized...
Eligibility Criteria
Inclusion
- persistent asthma
- exacerbation, previous 12 months
- evidence of mouse sensitization
- high levels of mouse allergen in home
- ages 5-17 years
Exclusion
- intermittent asthma
- no exacerbation in previous 12 months
- not sensitized to mouse
- low or undetectable mouse allergen in home
- other lung disease aside from asthma
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT01251224
Start Date
November 1 2010
End Date
September 1 2016
Last Update
March 16 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins
Baltimore, Maryland, United States, 21287
2
Boston Children's
Boston, Massachusetts, United States, 02210